西藏药业：拟1.7亿元至2亿元回购公司股份
TIBET PHARMA(SH:600211) Jing Ji Guan Cha Wang·2025-12-19 02:09Group 1 - The company, Tibet Pharmaceutical (600211), announced a share repurchase plan with a budget of 170 million to 200 million yuan, with a maximum repurchase price of 55 yuan per share [1]